Projet PANG (Horizon 2020, appel à projets 2015)
Action : Staff Exchanges
Panel : Chemistry
Statut du projet : CLOSED

Complications related to infectious diseases have significantly reduced, particularly in the developed countries, due to the availability and use of broad-range antibiotics and wide variety of antimicrobial agents. Excessive use of antibiotics and antimicrobial agents increased significantly the number of multi-drug resistant (MDR) bacteria. This has resulted in a serious threat to public health. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the low rate of emergence of new clinically useful antibiotics, has refocused attention on finding alternatives to overcome antimicrobial resistance. Novel strategies aiming to reduce the amount of antibiotics, but able to prevent and treat animal and human infections should be investigated, evidenced and approved. Among the various approaches, the use of graphene and its derivatives is currently considered a highly promising strategy to overcome microbial drug resistance. In line with this interest in graphene by the European Commission through the graphene ‘flagship’ initiatives, we respond in this consortium by exploring the utility of novel graphene based nanocomposites for the management and better understanding of microbial infections. The anti-microbical potential of the novel graphene based nanomaterials, the possibility of using such structures for the development of non-invase therapies together with the understanding of the mechanism of action will be the main focal points of the proposed project entitled “PANG”, relating to Pathogen and Graphene. We have gathered the essential elements, namely different academic institutions in Europe (France, Germany, and Sweden) and their associated countries (Ukraine) as well as two European companies (Graphenea-Spain and LSO Medical-France) and one company (RS RESEARCH) in one of the associated countries (Turkey). The proposed multidisciplinary project uniquely suits high-level interdisciplinary and cross-border training.

Mots clés : graphene, reduced graphene oxide, antibacterial, pathogen, plasmonic, glycobiology, photothermal treatment

Participants :
- Universitätsklinikum Erlangen (Allemagne) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 45000.0 €
- Graphenea (Spain) (Espagne) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 49500.0 €
- Danylo Halytsky Lviv National Medical University (Ukraine) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 76500.0 €
- Ruhr University Bochum (Allemagne) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 72000.0 €
- Rs arastirma egitim danismanlik ilac sanayi ticaret anonim sirketi (Turquie) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 157500.0 €
- LSO Medical (France) — Partner, beneficiary, Organismes privés (hors enseignement), subvention : 49500.0 €
- University of Gothenburg (Suède) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 22500.0 €
- Université de Lille (France) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 108000.0 €